Allied Investment Advisors LLC acquired a new stake in Everus (NYSE:ECG - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,549 shares of the company's stock, valued at approximately $365,000.
Other hedge funds have also recently added to or reduced their stakes in the company. New York State Common Retirement Fund bought a new position in shares of Everus in the fourth quarter valued at $3,472,000. HighMark Wealth Management LLC acquired a new stake in shares of Everus in the 4th quarter worth about $28,000. D.A. Davidson & CO. bought a new position in Everus in the 4th quarter valued at about $1,241,000. Truist Financial Corp acquired a new position in Everus during the 4th quarter valued at about $421,000. Finally, CIBC Asset Management Inc bought a new stake in Everus during the 4th quarter worth approximately $220,000.
Everus Stock Performance
Shares of ECG traded down $2.94 on Friday, reaching $43.60. 747,659 shares of the company's stock traded hands, compared to its average volume of 705,493. The business has a 50 day moving average price of $66.33. Everus has a 52-week low of $40.05 and a 52-week high of $77.93. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47.
Everus (NYSE:ECG - Get Free Report) last announced its earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, sell-side analysts forecast that Everus will post 2.49 earnings per share for the current year.
Analysts Set New Price Targets
ECG has been the topic of a number of recent research reports. DA Davidson began coverage on Everus in a report on Monday, November 4th. They issued a "neutral" rating and a $55.00 target price on the stock. Wolfe Research initiated coverage on Everus in a research note on Tuesday, December 3rd. They set a "peer perform" rating on the stock. Stifel Nicolaus reduced their target price on shares of Everus from $85.00 to $67.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Oppenheimer increased their target price on shares of Everus from $70.00 to $80.00 and gave the company an "outperform" rating in a report on Tuesday, January 7th.
Read Our Latest Report on ECG
Insider Buying and Selling
In other news, Director Rocca Michael Della acquired 1,050 shares of Everus stock in a transaction on Tuesday, February 18th. The stock was acquired at an average cost of $47.56 per share, with a total value of $49,938.00. Following the completion of the acquisition, the director now owns 2,027 shares in the company, valued at approximately $96,404.12. This trade represents a 107.47 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
About Everus
(
Free Report)
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Further Reading

Before you consider Everus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Everus wasn't on the list.
While Everus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.